Total Payments
$37,896
2018 Payments
$17,502
Companies
6
Transactions
40
Payment Breakdown by Category
Consulting$13,169 (34.8%)
Research$10,184 (26.9%)
Other$8,264 (21.8%)
Travel$4,931 (13.0%)
Food & Beverage$1,348 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,169 | 3 | 34.8% |
| Unspecified | $10,184 | 3 | 26.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,264 | 2 | 21.8% |
| Travel and Lodging | $4,931 | 16 | 13.0% |
| Food and Beverage | $1,348 | 16 | 3.6% |
Payments by Type
General
$27,712
37 transactions
Research
$10,184
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $31,280 | 26 | $0 (2018) |
| Puma Biotechnology, Inc. | $5,706 | 8 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $688.34 | 3 | $0 (2018) |
| Genentech USA, Inc. | $139.49 | 1 | $0 (2017) |
| Celgene Corporation | $70.63 | 1 | $0 (2017) |
| PFIZER INC. | $11.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $17,502 | 18 | Novartis Pharmaceuticals Corporation ($11,108) |
| 2017 | $20,394 | 22 | Novartis Pharmaceuticals Corporation ($20,173) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2018 | Teva Pharmaceuticals USA, Inc. | — | Travel and Lodging | In-kind items and services | $366.60 | General |
| 12/08/2018 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $316.52 | General |
| 12/08/2018 | Teva Pharmaceuticals USA, Inc. | — | Travel and Lodging | In-kind items and services | $5.22 | General |
| 12/05/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $45.68 | General |
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Consulting Fee | Cash or cash equivalent | $4,905.00 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Travel and Lodging | Cash or cash equivalent | $716.40 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Travel and Lodging | Cash or cash equivalent | $12.42 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Oncology | ||||||
| 03/08/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | AFINITOR (Drug) | — | In-kind items and services | $2,234.33 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
| 03/08/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Travel and Lodging | In-kind items and services | $976.42 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Travel and Lodging | Cash or cash equivalent | $250.00 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $42.59 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Travel and Lodging | In-kind items and services | $373.00 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | AFINITOR (Drug) | — | In-kind items and services | $7,185.67 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
| 12/12/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | AFINITOR (Drug) | — | In-kind items and services | $764.00 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
| 12/06/2017 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $120.46 | General |
| 06/26/2017 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,088.00 | General |
| 06/04/2017 | Genentech USA, Inc. | Herceptin (Biological) | Food and Beverage | In-kind items and services | $139.49 | General |
| Category: BioOncology | ||||||
| 06/03/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $70.63 | General |
| 06/02/2017 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $121.82 | General |
| 06/02/2017 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $20.25 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $10,184 | 3 |
About Melanie Royce, MD, PHD
Melanie Royce, MD, PHD is a Internal Medicine healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124049366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melanie Royce, MD, PHD has received a total of $37,896 in payments from pharmaceutical and medical device companies, with $17,502 received in 2018. These payments were reported across 40 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($13,169).
Ad
Practice Information
- Specialty Internal Medicine
- Location Albuquerque, NM
- Active Since 07/22/2006
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124049366
Products in Payments
- KISQALI (Drug) $17,058
- AFINITOR (Drug) $11,826
- Nerlynx (Drug) $5,706
- Herceptin (Biological) $139.49
- IBRANCE (Drug) $11.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Albuquerque
Lana Melendres-Groves, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Edward Lewiecki, M.d, M.D
Internal Medicine — Payments: $517,606
Internal Medicine $517,606
Ursa Brown-Glaberman, M.d, M.D
Internal Medicine — Payments: $280,882
Internal Medicine $280,882
Dr. Satyaki Banerjee, M.d.,Fasn, M.D.,FASN
Internal Medicine — Payments: $244,744
Internal Medicine $244,744
Dr. Yaw Adjei-Poku, M.d, M.D
Internal Medicine — Payments: $179,687
Internal Medicine $179,687
Lance Rudolph, M.d, M.D
Internal Medicine — Payments: $44,783
Internal Medicine $44,783